The fund owned 8,294 shares of the biopharmaceutical company’s stock after selling 4,203 shares during the period. Bristol now has $102.69 billion valuation. The stock decreased 0.35% or $0.22 during the last trading session, reaching $62.62. About 6,689 shares traded. Inv Mngmt Of Virginia Ltd Liability Corp has 0.4% invested in Bristol-Myers Squibb Co (NYSE:BMY). Washington Tru National Bank & Trust holds 0.15% or 11,034 shares. Its up 45.74% from 4.63M shares previously.
Weber Alan W holds 2.28% of its portfolio in Information Services Group, Inc. for 1.04 million shares. The stock declined 0.19% or $0.12 reaching $62.5 on the news.
Tuttle Tactical Management Llc increased Apple Inc (AAPL) stake by 42.02% reported in 2016Q4 SEC filing. It has underperformed by 13.94% the S&P500.
Investors sentiment increased to 0.68 in Q4 2016.
Since January 1, 0001, it had 0 buys, and 7 sales for $1.06 million activity. About 601 shares traded. Keating Invest Counselors has 38,182 shares for 1.05% of their portfolio. First Dallas Securities Inc accumulated 4,064 shares. Moreover, Tower Research Lc (Trc) has 0% invested in Versartis Inc (NASDAQ:VSAR). Ordinary Shares (NYSE:MDT). Gould Asset Limited Liability Com Ca invested in 0.38% or 10,449 shares. Independent owns 49,520 shares. 122,998 were reported by Dnb Asset Management As.
Insider Trades for Bristol-Myers Squibb Company show that the latest trade was made on 2 Sep 2017 where Nielsen Anne, the Officer completed a transaction type “Buy” in which 1594 shares were traded at a price of $0. Alliancebernstein Lp has 0% invested in Versartis Inc (NASDAQ:VSAR) for 13,600 shares. Teachers Retirement Systems Of The State Of Kentucky has invested 0.07% in Vantiv Inc (NYSE:VNTV). Baillie Gifford invested in 0.02% or 186,381 shares. Strs Ohio holds 1.65M shares. Massmutual Trust Communication Fsb Adv invested in 29,066 shares. Trustmark Retail Bank Tru Department stated it has 0.03% in Vantiv Inc (NYSE:VNTV). Profund Advsrs Ltd has invested 0.17% in Medtronic plc. Susquehanna maintained the shares of AAPL in report on Wednesday, October 28 with “Buy” rating. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Therefore 89% are positive. Mobileye had 45 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Buy” rating by Berenberg given on Friday, January 22. Jefferies maintained it with “Buy” rating and $66.0 target in Wednesday, August 23 report. RBC Capital Markets maintained the shares of AAPL in report on Friday, September 11 with “Buy” rating. The stock has “Hold” rating by Jefferies on Thursday, August 27. The company was downgraded on Friday, July 29 by Barclays Capital. Barclays Capital maintained it with “Equal-Weight” rating and $65 target in Friday, September 9 report. The firm has “Buy” rating by Guggenheim given on Wednesday, December 2. The firm earned “Overweight” rating on Tuesday, October 4 by Piper Jaffray. The insider Malik Shahzad sold 483,670 shares worth $8.76M. Shares for $928,551 were sold by Heimbouch Mark L on Monday, May 1. Ramsay Stattman Vela And Price Inc holds 2.86% of its portfolio in Apple Inc. The Firm conducts its activities through its subsidiary, Vantiv Holding, LLC. The company has market cap of $160.15 million. The Firm is a payment processor. It has a 20.66 P/E ratio. The Company’s divisions include Merchant Services and Financial Institution Services. Following the completion of the transaction, the senior vice president now directly owns 46,297 shares of the company’s stock, valued at approximately $2,777,820. Amazon.Com Inc (NASDAQ:AMZN) was raised too. The stock of Bristol-Myers Squibb Co (NYSE:BMY) has “Sell” rating given on Monday, June 5 by BMO Capital Markets.
For the Current Quarter, the growth estimate for Bristol-Myers Squibb Company is -1.3%, while for the Next Quarter the stock growth estimate is 1.6%. On Wednesday, March 15 the insider Caldarella Joseph C sold $463,779. Therefore 32% are positive. Bristol-Myers Squibb had a return on equity of 28.98% and a net margin of 18.54%. The rating was initiated by Robert W. Baird on Wednesday, April 26 with “Outperform”. The rating was initiated by Credit Suisse with “Neutral” on Thursday, August 20. The rating was maintained by Deutsche Bank on Monday, July 17 with “Hold”. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since September 11, 2016 and is downtrending. SunTrust has “Buy” rating and $25 target.
Investors sentiment decreased to 0.95 in 2016 Q4. Its down 0.74, from 2.13 in 2016Q3. It dived, as 86 investors sold BMY shares while 529 reduced holdings.
A number of other hedge funds have also recently added to or reduced their stakes in the business. Hemenway Trust Co LLC now owns 10,810 shares of the biopharmaceutical company’s stock valued at $602,000 after purchasing an additional 1,480 shares during the last quarter. Jones Financial Lllp invested in 4,619 shares or 0% of the stock. The Michigan-based Columbia Asset Mngmt has invested 0.31% in Bristol-Myers Squibb Co (NYSE:BMY). Financial Bank Of The West holds 0.23% or 28,562 shares. Agran Libbie owns 14,967 shares. Meristem Llp holds 17,418 shares or 0.42% of its portfolio. The biopharmaceutical company reported $0.74 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.01.
Several analysts have released their opinion on Bristol-Myers Squibb Company (NYSE:BMY), with 5 analysts believing it is a strong buy.
Director, Andreotti Lamberto, sold 34,000 common shares of Bristol-Myers Squibb Company (BMY) in the open market. Bonness Incorporated has 54,100 shares.
Bristol-Myers Squibb (NYSE:BMY) last posted its quarterly earnings results on Thursday, October 27th.
